Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurosurgery | 9 | 2024 | 682 | 2.280 |
Why?
|
Developing Countries | 12 | 2024 | 2913 | 1.340 |
Why?
|
Pituitary Neoplasms | 4 | 2024 | 1324 | 1.320 |
Why?
|
Meningioma | 6 | 2024 | 1221 | 1.130 |
Why?
|
Motorcycles | 2 | 2017 | 42 | 1.100 |
Why?
|
Head Protective Devices | 2 | 2017 | 118 | 1.020 |
Why?
|
Neurosurgical Procedures | 13 | 2024 | 2077 | 0.980 |
Why?
|
Brain Neoplasms | 16 | 2024 | 9101 | 0.800 |
Why?
|
Meningeal Neoplasms | 6 | 2024 | 1255 | 0.800 |
Why?
|
Cerebral Revascularization | 2 | 2022 | 260 | 0.780 |
Why?
|
Accidents, Traffic | 2 | 2017 | 818 | 0.750 |
Why?
|
Moyamoya Disease | 2 | 2022 | 274 | 0.740 |
Why?
|
Eccrine Glands | 1 | 2020 | 52 | 0.670 |
Why?
|
Aneurysm | 2 | 2019 | 343 | 0.640 |
Why?
|
Skull Neoplasms | 1 | 2020 | 173 | 0.640 |
Why?
|
Aneurysm, Ruptured | 1 | 2023 | 455 | 0.620 |
Why?
|
Codes of Ethics | 1 | 2018 | 61 | 0.610 |
Why?
|
Sweat Gland Neoplasms | 1 | 2020 | 111 | 0.600 |
Why?
|
Therapies, Investigational | 1 | 2018 | 110 | 0.570 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2018 | 131 | 0.570 |
Why?
|
Hematoma, Epidural, Cranial | 1 | 2016 | 59 | 0.540 |
Why?
|
Skull Base Neoplasms | 2 | 2020 | 280 | 0.530 |
Why?
|
Adenoma | 2 | 2024 | 2155 | 0.530 |
Why?
|
Alcoholic Intoxication | 1 | 2016 | 171 | 0.510 |
Why?
|
Cerebral Angiography | 2 | 2019 | 1263 | 0.510 |
Why?
|
Craniopharyngioma | 1 | 2018 | 279 | 0.490 |
Why?
|
Specialties, Surgical | 1 | 2018 | 391 | 0.440 |
Why?
|
Spinal Neoplasms | 1 | 2020 | 714 | 0.430 |
Why?
|
Ethics, Medical | 1 | 2018 | 785 | 0.420 |
Why?
|
Embolization, Therapeutic | 1 | 2022 | 1403 | 0.410 |
Why?
|
Intracranial Aneurysm | 1 | 2021 | 1271 | 0.380 |
Why?
|
Craniotomy | 4 | 2023 | 736 | 0.340 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2016 | 616 | 0.340 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2024 | 9404 | 0.330 |
Why?
|
Sarcoma | 1 | 2020 | 1802 | 0.320 |
Why?
|
Neurology | 1 | 2017 | 785 | 0.320 |
Why?
|
Brain Diseases | 1 | 2018 | 1552 | 0.310 |
Why?
|
Carcinoma | 1 | 2020 | 2324 | 0.310 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2016 | 957 | 0.300 |
Why?
|
Spinal Injuries | 2 | 2021 | 300 | 0.300 |
Why?
|
Patient Readmission | 2 | 2020 | 3283 | 0.290 |
Why?
|
Angiography, Digital Subtraction | 2 | 2019 | 331 | 0.290 |
Why?
|
Cambodia | 2 | 2017 | 185 | 0.270 |
Why?
|
Neuroma, Acoustic | 2 | 2020 | 456 | 0.250 |
Why?
|
Head and Neck Neoplasms | 1 | 2020 | 2929 | 0.250 |
Why?
|
Middle Cerebral Artery | 2 | 2023 | 271 | 0.240 |
Why?
|
Medical Oncology | 1 | 2017 | 2340 | 0.240 |
Why?
|
Humans | 61 | 2024 | 766766 | 0.240 |
Why?
|
Consultants | 1 | 2024 | 57 | 0.220 |
Why?
|
Hyperostosis | 1 | 2022 | 29 | 0.210 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 1 | 2023 | 64 | 0.210 |
Why?
|
Streptococcus anginosus | 1 | 2022 | 25 | 0.200 |
Why?
|
Retreatment | 1 | 2024 | 598 | 0.200 |
Why?
|
Gliosarcoma | 1 | 2021 | 115 | 0.180 |
Why?
|
Neurofibromatosis 2 | 1 | 2024 | 387 | 0.180 |
Why?
|
Carotid Artery, Internal | 1 | 2023 | 440 | 0.180 |
Why?
|
Retrospective Studies | 13 | 2024 | 81635 | 0.180 |
Why?
|
Hospital Charges | 1 | 2023 | 345 | 0.180 |
Why?
|
Glioblastoma | 4 | 2024 | 3458 | 0.170 |
Why?
|
Platybasia | 1 | 2020 | 10 | 0.170 |
Why?
|
Essential Tremor | 1 | 2022 | 160 | 0.170 |
Why?
|
Meningitis, Pneumococcal | 1 | 2020 | 43 | 0.170 |
Why?
|
Brain Stem Infarctions | 1 | 2020 | 31 | 0.170 |
Why?
|
Skull Base | 2 | 2024 | 294 | 0.170 |
Why?
|
Carcinoma, Ductal | 1 | 2020 | 96 | 0.160 |
Why?
|
Oncolytic Virotherapy | 2 | 2024 | 520 | 0.160 |
Why?
|
Malpractice | 1 | 2024 | 561 | 0.160 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2024 | 1787 | 0.160 |
Why?
|
Pneumatosis Cystoides Intestinalis | 1 | 2019 | 31 | 0.160 |
Why?
|
Spinal Cord Diseases | 1 | 2022 | 291 | 0.160 |
Why?
|
Length of Stay | 3 | 2023 | 6490 | 0.160 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1733 | 0.150 |
Why?
|
Medulla Oblongata | 1 | 2020 | 247 | 0.150 |
Why?
|
Abdominal Wall | 1 | 2020 | 166 | 0.150 |
Why?
|
Spinal Puncture | 1 | 2020 | 284 | 0.150 |
Why?
|
International Cooperation | 1 | 2024 | 1434 | 0.150 |
Why?
|
Choroid Plexus | 1 | 2020 | 249 | 0.140 |
Why?
|
Oncolytic Viruses | 1 | 2021 | 344 | 0.140 |
Why?
|
Scalp | 1 | 2020 | 390 | 0.140 |
Why?
|
Hyperplasia | 1 | 2020 | 1150 | 0.140 |
Why?
|
Receptor, Notch1 | 1 | 2020 | 518 | 0.140 |
Why?
|
Health Services Accessibility | 5 | 2024 | 5514 | 0.130 |
Why?
|
Surgery, Computer-Assisted | 1 | 2024 | 996 | 0.130 |
Why?
|
Brain | 3 | 2024 | 27159 | 0.130 |
Why?
|
Stroke | 3 | 2023 | 9741 | 0.130 |
Why?
|
Male | 18 | 2024 | 364142 | 0.130 |
Why?
|
Herpesvirus 1, Human | 1 | 2021 | 743 | 0.130 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2023 | 1023 | 0.120 |
Why?
|
Middle Aged | 14 | 2024 | 223257 | 0.120 |
Why?
|
Preoperative Period | 1 | 2018 | 564 | 0.120 |
Why?
|
DNA Repeat Expansion | 1 | 2015 | 74 | 0.120 |
Why?
|
Biomedical Technology | 1 | 2017 | 210 | 0.120 |
Why?
|
Trauma Severity Indices | 1 | 2016 | 479 | 0.120 |
Why?
|
Spinal Fractures | 1 | 2021 | 702 | 0.120 |
Why?
|
Equipment and Supplies | 1 | 2017 | 273 | 0.120 |
Why?
|
Spinal Fusion | 2 | 2021 | 1307 | 0.120 |
Why?
|
Hospitals, Pediatric | 1 | 2023 | 1851 | 0.120 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3609 | 0.110 |
Why?
|
Female | 18 | 2024 | 396520 | 0.110 |
Why?
|
Endoscopy | 1 | 2024 | 1854 | 0.110 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2015 | 432 | 0.110 |
Why?
|
Spinal Cord Injuries | 1 | 2021 | 927 | 0.110 |
Why?
|
Semantics | 1 | 2017 | 609 | 0.110 |
Why?
|
Hydrocephalus | 1 | 2020 | 766 | 0.110 |
Why?
|
Preoperative Care | 1 | 2022 | 2253 | 0.110 |
Why?
|
Steroids | 1 | 2018 | 936 | 0.110 |
Why?
|
Postoperative Complications | 4 | 2023 | 15831 | 0.110 |
Why?
|
Health Services Research | 1 | 2020 | 1811 | 0.100 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26310 | 0.100 |
Why?
|
Adult | 10 | 2024 | 223307 | 0.100 |
Why?
|
Patient Care Planning | 1 | 2018 | 904 | 0.100 |
Why?
|
Informed Consent | 1 | 2019 | 1010 | 0.100 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2021 | 2056 | 0.100 |
Why?
|
Internship and Residency | 2 | 2023 | 5943 | 0.100 |
Why?
|
Open Reading Frames | 1 | 2015 | 818 | 0.100 |
Why?
|
Aged | 11 | 2024 | 171343 | 0.100 |
Why?
|
Sex Distribution | 1 | 2016 | 2274 | 0.090 |
Why?
|
Cohort Studies | 4 | 2024 | 41710 | 0.090 |
Why?
|
Age Distribution | 1 | 2016 | 2869 | 0.090 |
Why?
|
Cerebrovascular Disorders | 1 | 2018 | 1479 | 0.090 |
Why?
|
Venous Thromboembolism | 2 | 2021 | 1882 | 0.090 |
Why?
|
Aged, 80 and over | 4 | 2020 | 59550 | 0.090 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 3236 | 0.080 |
Why?
|
Neoplasms, Experimental | 1 | 2015 | 1227 | 0.080 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2015 | 504 | 0.080 |
Why?
|
Glasgow Coma Scale | 2 | 2021 | 574 | 0.080 |
Why?
|
Students, Medical | 1 | 2022 | 1962 | 0.080 |
Why?
|
Recurrence | 1 | 2021 | 8507 | 0.080 |
Why?
|
Veterans | 1 | 2023 | 2667 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2020 | 1945 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8540 | 0.080 |
Why?
|
Neoplasms | 1 | 2017 | 22350 | 0.070 |
Why?
|
Reoperation | 1 | 2018 | 4325 | 0.070 |
Why?
|
Insurance, Health | 1 | 2020 | 2520 | 0.070 |
Why?
|
Adipocytes | 1 | 2015 | 1196 | 0.070 |
Why?
|
Health Policy | 1 | 2020 | 2698 | 0.070 |
Why?
|
Young Adult | 4 | 2018 | 59939 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2823 | 0.070 |
Why?
|
Nervous System Diseases | 1 | 2018 | 1659 | 0.070 |
Why?
|
Emergency Medical Services | 1 | 2019 | 1936 | 0.070 |
Why?
|
Hospitals | 1 | 2020 | 3888 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2015 | 2870 | 0.070 |
Why?
|
Delivery of Health Care | 2 | 2024 | 5368 | 0.070 |
Why?
|
Adolescent | 4 | 2021 | 88904 | 0.070 |
Why?
|
Quality Improvement | 2 | 2018 | 3850 | 0.060 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1931 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2024 | 65273 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8621 | 0.060 |
Why?
|
Incidence | 3 | 2021 | 21525 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3411 | 0.060 |
Why?
|
Cell Movement | 1 | 2016 | 5199 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2015 | 1663 | 0.060 |
Why?
|
Information Management | 1 | 2024 | 100 | 0.060 |
Why?
|
Risk Factors | 4 | 2021 | 74881 | 0.060 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3944 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2016 | 2596 | 0.050 |
Why?
|
Survival Rate | 1 | 2016 | 12825 | 0.050 |
Why?
|
Immunotherapy | 1 | 2018 | 4747 | 0.050 |
Why?
|
Time | 1 | 2024 | 550 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2018 | 8926 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 5 | 2022 | 36567 | 0.050 |
Why?
|
Temporal Arteries | 1 | 2022 | 155 | 0.040 |
Why?
|
Tetraploidy | 1 | 2020 | 28 | 0.040 |
Why?
|
Proteins | 1 | 2015 | 6002 | 0.040 |
Why?
|
Pituitary Gland | 1 | 2023 | 635 | 0.040 |
Why?
|
Internal Fixators | 1 | 2021 | 183 | 0.040 |
Why?
|
United States | 4 | 2024 | 72951 | 0.040 |
Why?
|
Klippel-Feil Syndrome | 1 | 2020 | 19 | 0.040 |
Why?
|
Neurofibromin 1 | 1 | 2021 | 190 | 0.040 |
Why?
|
Lumbosacral Region | 1 | 2021 | 294 | 0.040 |
Why?
|
Odontoid Process | 1 | 2020 | 46 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20708 | 0.040 |
Why?
|
Critical Pathways | 1 | 2023 | 475 | 0.040 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2020 | 186 | 0.040 |
Why?
|
Ventriculostomy | 1 | 2020 | 132 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13643 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2020 | 534 | 0.040 |
Why?
|
Abscess | 1 | 2022 | 606 | 0.040 |
Why?
|
Child | 2 | 2023 | 80668 | 0.040 |
Why?
|
Skull | 1 | 2022 | 819 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 705 | 0.040 |
Why?
|
Aftercare | 1 | 2024 | 915 | 0.040 |
Why?
|
Cadaver | 1 | 2022 | 1362 | 0.040 |
Why?
|
Operating Rooms | 1 | 2024 | 790 | 0.040 |
Why?
|
Herpes Simplex | 1 | 2021 | 470 | 0.040 |
Why?
|
Technology Transfer | 1 | 2017 | 41 | 0.040 |
Why?
|
Prospective Studies | 2 | 2022 | 54871 | 0.040 |
Why?
|
Mutation | 2 | 2021 | 30213 | 0.040 |
Why?
|
Hospitalization | 1 | 2017 | 10823 | 0.040 |
Why?
|
Policy Making | 1 | 2020 | 547 | 0.030 |
Why?
|
Telomerase | 1 | 2021 | 750 | 0.030 |
Why?
|
Postoperative Care | 1 | 2023 | 1480 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 8066 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2024 | 3552 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1117 | 0.030 |
Why?
|
Nuclear Pore | 1 | 2015 | 61 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1900 | 0.030 |
Why?
|
Language | 1 | 2024 | 1550 | 0.030 |
Why?
|
Streptococcus pneumoniae | 1 | 2020 | 764 | 0.030 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2016 | 616 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2015 | 520 | 0.030 |
Why?
|
G-Quadruplexes | 1 | 2015 | 144 | 0.030 |
Why?
|
Oligonucleotides, Antisense | 1 | 2015 | 462 | 0.030 |
Why?
|
Cerebellum | 1 | 2020 | 1520 | 0.030 |
Why?
|
Frontotemporal Dementia | 1 | 2015 | 249 | 0.030 |
Why?
|
GTPase-Activating Proteins | 1 | 2015 | 465 | 0.020 |
Why?
|
Cerebral Hemorrhage | 1 | 2023 | 2654 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2021 | 1878 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2948 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2023 | 2418 | 0.020 |
Why?
|
Urinary Tract Infections | 1 | 2016 | 804 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29948 | 0.020 |
Why?
|
Mice, SCID | 1 | 2015 | 2628 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2023 | 3799 | 0.020 |
Why?
|
Equipment Design | 1 | 2017 | 3487 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9661 | 0.020 |
Why?
|
Curriculum | 1 | 2022 | 3783 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8351 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3531 | 0.020 |
Why?
|
Medicaid | 1 | 2020 | 2836 | 0.020 |
Why?
|
Clinical Competence | 1 | 2022 | 4858 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2662 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2015 | 1725 | 0.020 |
Why?
|
Animals | 4 | 2024 | 168930 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 2015 | 1704 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5783 | 0.020 |
Why?
|
RNA | 1 | 2015 | 2715 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9525 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8045 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18397 | 0.010 |
Why?
|
Nanoparticles | 1 | 2016 | 1966 | 0.010 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2015 | 1481 | 0.010 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2015 | 1882 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14652 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13278 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5795 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11872 | 0.010 |
Why?
|
Melanoma | 1 | 2019 | 5700 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5387 | 0.010 |
Why?
|
Glioma | 1 | 2015 | 3498 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39309 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 17088 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16724 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36461 | 0.010 |
Why?
|
Neurons | 1 | 2015 | 9515 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81889 | 0.000 |
Why?
|
Concepts
(246)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(72)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_